176 related articles for article (PubMed ID: 2340372)
1. Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
Aass N; Fosså SD; Ous S; Lien HH; Stenwig AE; Paus E; Kaalhus O
Br J Urol; 1990 Apr; 65(4):385-90. PubMed ID: 2340372
[TBL] [Abstract][Full Text] [Related]
2. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I.
Fosså SD; Klepp O; Ous S; Lien HH; Stenwig AE; Abyholm T; Kaalhus O
Eur Urol; 1984; 10(1):17-23. PubMed ID: 6698081
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
4. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
[TBL] [Abstract][Full Text] [Related]
5. Nerve-sparing retroperitoneal lymphadenectomy for low stage testicular cancer.
de Bruin MJ; Oosterhof GO; Debruyne FM
Br J Urol; 1993 Mar; 71(3):336-9. PubMed ID: 8386581
[TBL] [Abstract][Full Text] [Related]
6. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
7. Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?
Sosnowski M; Jeromin L; Płuzańska A
Int Urol Nephrol; 1994; 26(4):471-7. PubMed ID: 7528180
[TBL] [Abstract][Full Text] [Related]
8. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
[TBL] [Abstract][Full Text] [Related]
9. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
10. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].
Matveev VB; Volkova MI; Cherniev VA; Figurin KM; Mitin AV
Urologiia; 2010; (3):41-7. PubMed ID: 20734877
[TBL] [Abstract][Full Text] [Related]
11. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
12. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
[TBL] [Abstract][Full Text] [Related]
13. [Nerve-sparing retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumors at clinical stage 1].
Ranieri A; Micheli E; Graziotti P; Tura M; Hurle RF; Romano C; Lembo A
Arch Ital Urol Androl; 1994 Feb; 66(1):15-8. PubMed ID: 8012420
[TBL] [Abstract][Full Text] [Related]
14. [Studies on retroperitoneal lymph node dissection concerning postoperative ejaculatory function in patients with testicular cancer].
Takasaki N; Okada S; Kawasaki T; Tonami H; Shimizu A; Ueno N; Hirai K; Miyazaki S
Hinyokika Kiyo; 1991 Mar; 37(3):213-9. PubMed ID: 2069101
[TBL] [Abstract][Full Text] [Related]
15. Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
von Amsberg G; Hamilton R; Papachristofilou A
Oncol Res Treat; 2018; 41(6):360-363. PubMed ID: 29763926
[TBL] [Abstract][Full Text] [Related]
16. An intra-operative seminal and prostate emission test as a control for nerve-sparing procedures in primary and secondary retroperitoneal lymphadenectomy.
Recker F; Goepel M; Otto T; Krege S; Wernli M; Stucki P; Tscholl R; Rübben H
Br J Urol; 1996 Jan; 77(1):133-7. PubMed ID: 8653284
[TBL] [Abstract][Full Text] [Related]
17. [Retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Jaeger P; Hauri D
Urologe A; 1988 Sep; 27(5):251-5. PubMed ID: 2845621
[TBL] [Abstract][Full Text] [Related]
18. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
19. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
20. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
